Metactive Medical Presents Results from Nonclinical Research Study

Metactive Medical, a Serra Capital III portfolio company, presented new nonclinical results from Metactive’s peripheral vascular research program at the Society of Interventional Radiology (SIR) Annual Scientific Meeting on July 23. The study was conducted on the treatment of peripheral arteries, and showed the effectiveness of Metactive's solution over other treatments. 

Metactive Medical is a medical device company developing innovative products for the treatment of neurovascular and peripheral vascular diseases.

Source: https://www.businesswire.com/news/home/20180723005192/en/Metactive-Presents-Results-Nonclinical-Research-Study-Treating